
Aptahem Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Aptahem
Access all reports
Aptahem AB is a Sweden-based biotechnology company specializing in the development of innovative therapies for severe and acute conditions. The company focuses on drug candidates that target inflammatory and coagulation disorders, such as sepsis and other life-threatening diseases. The company is headquartered in Malmö, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
APTA
Country
🇸🇪 Sweden